Orchestra BioMed Holdings, Inc. · NASDAQ:OBIO

Orchestra BioMed Holdings, Inc. financial statements

Orchestra BioMed Holdings, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue33.5M2.64M2.76M3.53M-782.0K5.70M
Cost of revenue190.0K204.0K186.0K211.0K199.0K145.0K
Gross profit33.3M2.43M2.57M3.21M-981.0K5.56M
Research and development58.2M42.8M33.8M21.9M12.9M13.5M
Selling, general and administrative26.9M23.9M20.3M14.0M7.93M10.8M
Operating income-51.8M-64.3M-51.5M-32.7M-394.8K-18.8M
Depreciation and amortization327.0K308.0K287.0K222.0K181.0K137.0K
EBITDA-51.5M-64.0M-51.2M-32.4M-213.8K-18.6M
Interest expense1.15M297.0K1.40M1.30M927.0K
Income before tax-52.7M-61.0M-49.1M-33.6M-23.0M-21.4M
Income tax0119.1K-222.0K927.0K2.60M
Net income-52.7M-61.0M-49.1M-33.6M-378.8K-21.4M
Earnings per share, basic-1.11-1.66-1.48-2.24-0.02-1.04
Earnings per share, diluted-1.11-1.66-1.48-2.24-0.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents34.7M22.3M30.6M19.8M1.75M20.3M
Short-term investments71.8M44.6M57.0M63.9M958.0K15.4M
Receivables95.0K92.0K99.0K96.0K121.0K168.0K
Inventory310.0K173.0K146.0K276.0K68.0K69.0K
Current assets107.9M69.2M89.1M84.7M1.80M36.3M
Property, plant and equipment1.72M1.38M1.28M1.49M1.12M1.03M
Total assets114.9M76.2M95.2M95.6M161.8M38.1M
Accounts payable6.09M5.13M2.90M3.97M1.39K1.77M
Current liabilities16.7M16.2M11.2M18.6M165.5K14.4M
Long-term debt14.3M14.3M9.49M3.67M5.46M
Total debt15.0M15.0M1.69M11.9M5.67M9.46M
Total liabilities51.5M43.2M27.2M43.0M5.77M86.6M
Shareholders' equity53.6M33.0M68.0M52.5M-19.8M-48.5M
Shares outstanding57.0M38.2M35.8M20.2M4.45M20.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-49.0M-50.6M-46.1M-29.3M-272.4K-26.2M
Capital spending-489.0K-289.0K-78.0K-591.0K-274.0K-539.0K
Free cash flow-49.5M-50.8M-46.2M-29.9M-19.7M-26.7M
Cash from investing-26.9M13.1M10.7M-64.1M13.0M27.0M
Cash from financing88.3M29.2M46.2M103.3M-3.99M10.0M
Share buybacks-92.6M
Change in cash12.4M-8.30M10.8M9.85M-272.4K10.8M